# PharmaZell Schweiz GmbH – FDA Inspection, Jan 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/pharmazell-schweiz-gmbh/f5827bd8-9dbf-4c95-be00-db99c5516ff0
Source feed: FDA_Inspections

> FDA inspection 1000396 of PharmaZell Schweiz GmbH, January 19, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000396
- Company Name: PharmaZell Schweiz GmbH
- Inspection Date: 2017-01-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Investigator](https://www.keypedia.com/people/sandra-a-boyd/c469103a-0917-407a-b9d1-98273358dfeb)

Company: https://www.keypedia.com/companies/pharmazell-schweiz-gmbh/106dcaa7-76a3-4d8f-a12c-29c68bb20032

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c